Although this data was acquired in a small patient population and although PD-L1 expression on tumor cells seems to be not a reliable predictive marker of response to checkpoint inhibitors yet15, we could show that in EOC both, MHC I down-regulation and PD-L1 expression need to be considered concurrently. Here, CD274 is linked to neoplasm.